Merck & Co. And Gates Foundation Drug Hunters Hopeful Of A TB Breakthrough

Not-For-Profit To Develop Merck’s Compounds

 
• By Andrew McConaghie
  
Lungs and pills
Before SARS-CoV-2, tuberculosis was the world’s biggest infectious disease killer, and with the pandemic waning it is expected to regain its title soon. • Source: Shutterstock

More from Clinical Trials

More from R&D